COMP <GO>
BCYC vs BIOA // REVENUE GROWTH (YOY)
Bicycle Therapeutics plc (NASDAQ) VS. BioAge Labs Inc. (NASDAQ) • 15-METRIC TALLY: BCYC 1
— BIOA 2
■ METRIC PARITY
LAST: $3.82 (-1.55%) • MKT CAP: $267.4M
revenue-growth
105.80%
LAST: $5.94 (0.00%) • MKT CAP: $272.6M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCYC VS. BIOA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCYC | BIOA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 105.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.66 | -5.46 | BIOA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 43.4 | +4.70 | BCYC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $267.4M | $272.6M | -$5.3M | BIOA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCYC REV | BIOA REV | BCYC GROSS % | BIOA GROSS % | BCYC FCF | BIOA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.6M | $9.0M | — | — | -$252.0M | -$82.3M |
| FY 2024 | $35.3M | $0 | — | — | -$166.0M | -$51.9M |
| FY 2023 | $27.0M | $0 | — | — | -$60.6M | -$37.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCYC // BETA —
BIOA // BETA —